Effects of intraperitoneal bevacizumab administration on colonic anastomosis and early postoperative adhesion formation.

Item

http://www.wikidata.org/entity/Q44487884

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Effects of intraperitoneal bev ...... toperative adhesion formation.

@en

Effects of intraperitoneal bev ...... toperative adhesion formation.

@nl

type

Item

label

Effects of intraperitoneal bev ...... toperative adhesion formation.

@en

Effects of intraperitoneal bev ...... toperative adhesion formation.

@nl

prefLabel

Effects of intraperitoneal bev ...... toperative adhesion formation.

@en

Effects of intraperitoneal bev ...... toperative adhesion formation.

@nl

P1476

Effects of intraperitoneal bev ...... toperative adhesion formation.

@en

P2093

Atilla Kurt

http://www.w3.org/2001/XMLSchema#string

Enver Kunduz

http://www.w3.org/2001/XMLSchema#string

Hasan Karanlik

http://www.w3.org/2001/XMLSchema#string

Hilal Oguz Soydinc

http://www.w3.org/2001/XMLSchema#string

Kursat Serin

http://www.w3.org/2001/XMLSchema#string

Oktar Asoglu

http://www.w3.org/2001/XMLSchema#string

Sezer Saglam

http://www.w3.org/2001/XMLSchema#string

Vakur Olgac

http://www.w3.org/2001/XMLSchema#string

Vildan Yasasever

http://www.w3.org/2001/XMLSchema#string

P2860

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer

Incidence and management of bevacizumab-related toxicities in colorectal cancer

Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer.

VEGF as a key mediator of angiogenesis in cancer.

Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei--a report of 103 procedures.

Strategies for management of the peritoneal surface component of cancer: cytoreductive surgery plus perioperative intraperitoneal chemotherapy.

A phase II study of high-dose bevacizumab in combination with irinotecan, 5-fluorouracil, leucovorin, as initial therapy for advanced colorectal cancer: results from the Eastern Cooperative Oncology Group study E2200.

Angiogenesis inhibition with bevacizumab and the surgical management of colorectal cancer.

Use of an anti-vascular endothelial growth factor antibody in a pharmacokinetic strategy to increase the efficacy of intraperitoneal chemotherapy.

Peritoneal seeding following potentially curative resection of colonic carcinoma: implications for adjuvant therapy.

P304

559-565

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1553350613480855

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236043311

http://www.w3.org/2001/XMLSchema#string

P698

23487032

http://www.w3.org/2001/XMLSchema#string

P921

bevacizumab